To further verify our conclusion, we performed a Kaplan-Meier survival analysis on the mutation data with complete clinical information in TCGA and ICGC database and also found that LRP1B mutations and TP53 mutations were significantly correlated with the prognosis of HCC patients (Figure 3A). This evidence concerns the gene TP53 and hepatocellular carcinoma.